Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Urothelial Cancer, Chinese Herbs Linked In NEJM Study

This article was originally published in The Tan Sheet

Executive Summary

Regular intake of powdered Chinese herbs containing aristolochic acids "dramatically increases the risk of urothelial cancer," Belgian and German researchers report in the June 8 issue of the New England Journal of Medicine.

You may also be interested in...



MCA Permanent Order Banning Aristolochia Use Proposed

The U.K.' s Medicines Control Agency has issued a proposal to continue, on a permanent basis, current provisions prohibiting the distribution of products containing the Aristolochia species or herbal ingredients that may be confused with the species.

MCA Permanent Order Banning Aristolochia Use Proposed

The U.K.' s Medicines Control Agency has issued a proposal to continue, on a permanent basis, current provisions prohibiting the distribution of products containing the Aristolochia species or herbal ingredients that may be confused with the species.

MCA Permanent Order Banning Aristolochia Use Proposed

The U.K.' s Medicines Control Agency has issued a proposal to continue, on a permanent basis, current provisions prohibiting the distribution of products containing the Aristolochia species or herbal ingredients that may be confused with the species.

Related Content

Topics

UsernamePublicRestriction

Register

PS091314

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel